Company: TVRD
Filing Date: 2025-01-27
Form Type: S-4/A
Source: 0001104659-25-006050
Chunk: 625

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-01-27
Form: S-4/A
Chunk 625
---
 issuance under the 2014 Plan has automatically increased on January 1 of each year, beginning on January 1, 2015 and continuing through and including January 1, 2024, by 3% of the total number of shares of Cara’s capital stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares determined by the Board. The maximum number of shares that may be issued pursuant to the exercise of incentive stock options under the 2014 Plan is 2,500,000 shares.

345

TVARDI’S EXECUTIVE AND DIRECTOR COMPENSATION Executive Compensation This section provides an overview of Tvardi’s executive compensation programs as they relate to the executive officers named below (named executive officers), including a narrative description of the material factors necessary to understand the information disclosed in the summary compensation table below. For the year ended December 31, 2024, Tvardi’s named executive officers were:

| ● | Imran Alibhai, Ph.D., Tvardi Chief Executive Officer and Director; |

| ● | John Kauh, M.D., Tvardi Chief Medical Officer; and |

| ● | Dan Conn, J.D., M.B.A., Tvardi Chief Financial Officer. |

2024 Summary Compensation Table The following table presents all of the compensation awarded to or earned by or paid to Tvardi’s named executive.

| ​                                    
 ​                                    
 ​                                    
 Name and Principal Position          | ​ 
 ​ 
 ​ |    ​ 
    ​ 
    ​ 
 Year | ​ 
 ​ 
 ​ | ​      
 ​      
 Salary 
 ($)    |       ​ 
       ​ | ​    
 ​    
 ​    | ​     
 ​     
 Bonus 
 ($)   |       ​ 
       ​ | ​    
 ​    
 ​    | ​             
 ​             
 Option awards 
 ($)(1)        |       ​ 
       ​ | ​ 
 ​ 
 ​ | ​            
 All other    
 compensation 
 ($)(3)       |      ​ | ​ 
 ​ 
 ​ | ​     
 ​     
 Total 
 ($)   |       ​ 
       ​ |
|:-------------------------------------|:--|-----:|:--|:-------|--------:|:-----|:------|--------:|:-----|:--------------|--------:|:--|:-------------|-------:|:--|:------|--------:|
| Imran Alibhai, Ph.D.                 | ​ | 2024 | ​ | $      | 551,050 |